Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines

被引:0
|
作者
Liying Yang
Kohei Kumegawa
Sumito Saeki
Tomoyoshi Nakadai
Reo Maruyama
机构
[1] Japanese Foundation for Cancer Research,Project for Cancer Epigenomics, Cancer Institute
[2] Japanese Foundation for Cancer Research,Cancer Cell Diversity Project, NEXT
[3] Japanese Foundation for Cancer Research,Ganken Program
来源
Cancer Gene Therapy | 2024年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is a heterogeneous disease, and breast cancer cell lines are invaluable for studying this heterogeneity. However, the epigenetic diversity across these cell lines remains poorly understood. In this study, we performed genome-wide chromatin accessibility analysis on 23 breast cancer cell lines, including 2 estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative (ER+/HER2−), 3 ER+/HER2+, 3 HER2+, and 15 triple-negative breast cancer (TNBC) lines. These cell lines were classified into three groups based on their chromatin accessibility: the receptor-positive group (Group-P), TNBC basal group (Group-B), and TNBC mesenchymal group (Group-M). Motif enrichment analysis revealed that only Group-P exhibited coenrichment of forkhead box A1 (FOXA1) and grainyhead-like 2 (GRHL2) motifs, whereas Group-B was characterized by the presence of the GRHL2 motif without FOXA1. Notably, Group-M did not show enrichment of either FOXA1 or GRHL2 motifs. Furthermore, gene ontology analysis suggested that group-specific accessible regions were associated with their unique lineage characteristics. To investigate the epigenetic landscape regulatory roles of FOXA1 and GRHL2, we performed knockdown experiments targeting FOXA1 and GRHL2, followed by assay for transposase-accessible chromatin sequencing analysis. The findings revealed that FOXA1 maintains Group-P–specific regions while suppressing Group-B–specific regions in Group-P cells. In contrast, GRHL2 preserves commonly accessible regions shared between Group-P and Group-B in Group-B cells, suggesting that FOXA1 and GRHL2 play a pivotal role in preserving distinct chromatin accessibility patterns for each group. Specifically, FOXA1 distinguishes between receptor-positive and TNBC cell lines, whereas GRHL2 distinguishes between basal-like and mesenchymal subtypes in TNBC lines.
引用
收藏
页码:736 / 745
页数:9
相关论文
共 5 条
  • [1] Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines
    Yang, Liying
    Kumegawa, Kohei
    Saeki, Sumito
    Nakadai, Tomoyoshi
    Maruyama, Reo
    CANCER GENE THERAPY, 2024, 31 (05) : 736 - 745
  • [2] FoxA1 as a lineage-specific oncogene in luminal type breast cancer
    Yamaguchi, Noritaka
    Ito, Emi
    Azuma, Sakura
    Honma, Reiko
    Yanagisawa, Yuka
    Nishikawa, Akira
    Kawamura, Mika
    Imai, Jun-ichi
    Tatsuta, Kuniaki
    Inoue, Jun-ichiro
    Semba, Kentaro
    Watanabe, Shinya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 365 (04) : 711 - 717
  • [3] The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer
    Cocce, Kimberly J.
    Jasper, Jeff S.
    Desautels, Taylor K.
    Everett, Logan
    Wardell, Suzanne
    Westerling, Thomas
    Baldi, Robert
    Wright, Tricia M.
    Tavares, Kendall
    Yllanes, Alex
    Bae, Yeeun
    Blitzer, Jeremy T.
    Logsdon, Craig
    Rakiec, Daniel P.
    Ruddy, David A.
    Jiang, Tiancong
    Broadwater, Gloria
    Hyslop, Terry
    Hall, Allison
    Leine, Muriel
    Phung, Linda
    Greene, Geoffrey L.
    Martin, Lesley-Ann
    Pancholi, Sunil
    Dowsett, Mitch
    Detre, Simone
    Marks, Jeffrey R.
    Crawford, Gregory E.
    Brown, Myles
    Norris, John D.
    Chang, Ching-yi
    McDonnell, Donald P.
    CELL REPORTS, 2019, 29 (04): : 889 - +
  • [4] Steroid receptors can facilitate the binding of each other and the pioneer factor FoxA1 to active enhancers in breast cancer cell lines through a dynamic assisted loading mechanism.
    Swinstead, E. E.
    Paakinaho, V.
    Presman, D. M.
    Miranda, T. B.
    Baek, S.
    Ball, D. A.
    Karpova, T. S.
    Hager, G. L.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [5] DNA microarray profiling of BRCA1 and BRCA2 deficient human tumors and cell-lines using a breast cancer specific platform
    Mulligan, Jude
    Farztdinov, Vadim
    Halfpenny, Iris
    Delaney, Thomas
    Tanney, Austin
    Oliver, Gavin
    Quinn, Jennifer
    Couch, Fergus
    Harkin, Paul
    Kerr, Peter
    Kennedy, Richard
    CANCER RESEARCH, 2009, 69